XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements Of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Redeemable Convertible Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Total
Balances at Dec. 31, 2019 [1] $ 72,661 $ 2 $ 1,754 $ (69,571) $ 41 $ (67,774)
Balances (in Shares) at Dec. 31, 2019 [1] 27,499,837 17,357,505        
Stock-based compensation expense 171 171
Foreign currency translation adjustment 6 6
Net income (loss) (3,941) (3,941)
Balance at Mar. 31, 2020 [1] $ 72,661 $ 2 1,925 (73,512) 47 (71,538)
Balance (in Shares) at Mar. 31, 2020 [1] 27,499,837 17,357,505        
Stock-based compensation expense 174 174
Foreign currency translation adjustment 10 10
Net income (loss) (5,819) (5,819)
Balance at Jun. 30, 2020 [1] $ 72,661 $ 2 2,099 (79,331) 57 (77,173)
Balance (in Shares) at Jun. 30, 2020 [1] 27,499,837 17,357,505        
Issuance of Series D Preferred Stock, net of issuance costs of $1.3 million [1] $ 35,051
Issuance of Series D Preferred Stock, net of issuance costs of $1.3 million (in Shares) [1] 7,896,922        
Issuance of Series D Preferred Stock in connection with the extinguishment of convertible promissory notes [1] $ 6,891
Issuance of Series D Preferred Stock in connection with the extinguishment of convertible promissory notes (in Shares) [1] 1,497,135        
Exercise of stock options [1] 2 2
Exercise of stock options (in Shares) [1] 2,663        
Stock-based compensation expense 209 209
Foreign currency translation adjustment 2 2
Net income (loss) (10,295) (10,295)
Balance at Sep. 30, 2020 [1] $ 114,603 $ 2 2,310 (89,626) 59 (87,255)
Balance (in Shares) at Sep. 30, 2020 [1] 36,893,894 17,360,168        
Balances at Dec. 31, 2020 $ 6 153,571 (153,561) 325 341
Balances (in Shares) at Dec. 31, 2020 59,526,171        
Exercise of stock options 50 50
Exercise of stock options (in Shares) 48,211        
Stock-based compensation expense 3,265 3,265
Foreign currency translation adjustment 24 24
Net income (loss) (39,756) (39,756)
Balance at Mar. 31, 2021 $ 6 156,886 (193,317) 349 (36,076)
Balance (in Shares) at Mar. 31, 2021 59,574,382        
Issuance of common stock upon the private offering 9,250 9,250
Issuance of common stock upon the private offering (in Shares) 960,540        
Exercise of stock options 58 58
Exercise of stock options (in Shares) 124,680        
Issuance of common stock upon vesting of restricted stock awards
Issuance of common stock upon vesting of restricted stock awards (in Shares) 21,989        
Stock-based compensation expense 4,255 4,255
Foreign currency translation adjustment (61) (61)
Net income (loss) (3,351) (3,351)
Balance at Jun. 30, 2021 $ 6 170,449 (196,668) 288 (25,925)
Balance (in Shares) at Jun. 30, 2021 60,681,591        
Exercise of stock options 319 319
Exercise of stock options (in Shares) 236,976        
Exercise of warrants 10 10
Exercise of warrants (in Shares) 1,002,250        
Exercise of underwriter’s option
Exercise of underwriter’s option (in Shares) 54,083        
Issuance of common stock upon vesting of restricted stock awards
Issuance of common stock upon vesting of restricted stock awards (in Shares) 202,120        
Stock-based compensation expense 2,425 2,425
Foreign currency translation adjustment (87) (87)
Net income (loss) 28,944 28,944
Balance at Sep. 30, 2021 $ 6 $ 173,203 $ (167,724) $ 201 $ 5,686
Balance (in Shares) at Sep. 30, 2021   62,177,020        
[1] Retroactively restated for the Reverse Recapitalization as described in Note 3